bpc-157 clinical trials trial dosing bpc 157 clinical BPC-157 Reconstitution and Dosing BPC-157 Dosing Guide: Protocol, Reconstitution bpc-157 human clinical trial safety

Our team generally advises against pre-filling syringes for extended periods

The compound is identical to the lyophilized vial format

BPC-157 primarily works by upregulating VEGF, a signaling protein that triggers the formation of new blood vessels (a process called angiogenesis)

Learn more and book an appointment today!

GLOW Peptide Storage & Handling Storage Reference (All Three Compounds) State Lyophilized (Powder Form) BPC-157 -4 F (-20 C) long-term TB-500 -4 F (-20 C) long-term GHK-Cu -4 F (-20 C) long-term State Reconstituted (Liquid Form) BPC-157 35.6-46.4 F (2-8 C), up to 30 days TB-500 35.6-46.4 F (2-8 C), 1-2 weeks GHK-Cu 35.6-46.4 F (2-8 C), up to 30 days State Appearance BPC-157 Clear TB-500 Clear GHK-Cu May be light blue/green State Freeze reconstituted BPC-157 Aliquots possible TB-500 Do not freeze GHK-Cu Do not freeze TB-500 has the shortest reconstituted-stability window

Conditions: The product arrived damaged or compromised, or an incorrect product was received, and the issue is reported with supporting documentation